The Food and Drug Administration removed the black box warning from hormone replacement therapies late last year, and ...
Don't blame a menopause fad. There is little incentive for pharmacy companies to ensure smooth, consistent access.
Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now available as a method of contraception for use in women of reproductive potential with a BMI Twirla® (levonorgestrel and ethinyl ...
Demand for estrogen patches surged 26% after the FDA removed a black box warning on hormone therapy in 2025 Shutterstock Demand for estrogen patches surged 26% after the FDA removed a black box ...
Bleeding Irregularities and Amenorrhea-Women using TWIRLA may experience unscheduled bleeding, especially during the first three months of use, or experience absence of scheduled bleeding. If bleeding ...
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial ...
If you’re considering hormone replacement therapy (HRT), it’s natural to wonder about the possible side effects. One common type of HRT is estrogen patches, which deliver estrogen through the skin to ...
The proportion of patients achieving a prostate-specific antigen nadir less than or equal to 0.2 ng/ml was exactly the same for patients treated with transdermal estradiol patches and those treated ...
Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results